The latest news in cancer research, health and policy by Cancer Research UK.
We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy.
Combining an immunotherapy with chemotherapy has been recommended as a treatment for some patients with lung cancer on the NHS in England.
Patients in England with a certain type of advanced breast cancer will not have access to a new drug comb, after it was given an initial no for NHS use.
Combining a targeted cancer drug with an immunotherapy extends the lives of advanced kidney cancer patients, according to two clinical trials.
A combination of chemotherapy drugs was better than a single drug at extending the lives of pancreatic cancer patients after surgery.